Michael Ellenberger

Michael Ellenberger

ID: 1b82610b-2619-30fb-68c4

/

Claimed Record

/

Organization: Rothwell Figg

Beyond Guinea Pigs: Patent Risks and Opportunities in AI-Enabled Drug Development

Biosimilars Law Bulletin · July 23, 2025

Biosimilars Boom: 2025’s Fast Track Approvals Look to Reshape Healthcare

Biosimilars Law Bulletin · July 16, 2025

Target Acquired, Protein Deleted: The Next Frontier in Precision Medicine and IP Strategy

RF EMerge · April 25, 2025

Key Patent Considerations for Antibody Drug Conjugates (ADCs)

RF EMerge · April 8, 2025

From Algorithms to Approvals: Navigating AI in Drug and Biological Product Regulation

Biosimilars Law Bulletin · February 13, 2025

Practice Areas

Health Care and Life Sciences

Business and Commercial

Jurisdictions

Washington, D.C.